{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:19:53Z","timestamp":1791389993079,"version":"4.3.3"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Rare diseases, most of which have a genetic basis, remain a major challenge due to diagnostic delays and limited therapeutic options, particularly within the Middle Eastern regions. These countries exhibit a heightened prevalence of genetic disorders attributable to their distinctive genetic architecture. Advances in long-read sequencing (LRS) technologies have significantly improved our ability to detect complex genetic variations, including structural variants (SVs), repeat expansions, and mutations in previously inaccessible genomic regions, thereby increasing the diagnostic yield in rare disease cohorts. In parallel, the rapid evolution of gene-editing platforms such as CRISPR\/Cas9, base editors, and prime editors has opened new possibilities for addressing the biological pathways of the disease and achieving precise therapeutic correction of pathogenic variants causing the disease. Importantly, the integration of LRS with gene-editing approaches establishes a continuum from accurate variant discovery and functional characterization to the development of personalized therapies. This review highlights recent progress in both fields, discusses their complementary roles in rare disease research, and explores the translational opportunities and ethical challenges of combining these technologies to advance precision medicine. In addition, the review addresses emerging ethical and regulatory considerations associated with the clinical translation of long-read sequencing and next-generation gene-editing technologies, particularly in the context of rare disease precision medicine.<\/jats:p>","DOI":"10.3389\/fmed.2026.1859881","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:10:20Z","timestamp":1783336220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-read sequencing and next-generation CRISPR editors: a unified pipeline for rare disease precision medicine with ethical and regulatory perspectives"],"prefix":"10.3389","volume":"13","author":[{"given":"Anshida","family":"Konamveettil Abdul Latheef","sequence":"first","affiliation":[{"name":"Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Farahat","sequence":"additional","affiliation":[{"name":"Faculty of Law, McGill University","place":["Montreal, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"Gourari","sequence":"additional","affiliation":[{"name":"Department of Public Law, College of Law, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"AlQodsi","sequence":"additional","affiliation":[{"name":"Department of Private Law, College of Law, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Akawi","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/pediatric15030043","article-title":"Barriers to and facilitators of providing care for adolescents suffering from rare diseases: a mixed systematic review.","volume":"15","author":"Tsitsani","year":"2023","journal-title":"Pediatr Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"579924","DOI":"10.3389\/fped.2020.579924","article-title":"Barriers and considerations for diagnosing rare diseases in indigenous populations.","volume":"8","author":"D\u2019Angelo","year":"2020","journal-title":"Front Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1243518","DOI":"10.3389\/fgene.2023.1243518","article-title":"Prospect of genetic disorders in Saudi Arabia.","volume":"14","author":"Alqahtani","year":"2023","journal-title":"Front Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13073-024-01307-6","article-title":"Burden of Mendelian disorders in a large Middle Eastern biobank.","volume":"16","author":"Aamer","year":"2024","journal-title":"Genome Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/jpm12030423","article-title":"Middle Eastern genetic variation improves clinical annotation of the human genome.","volume":"12","author":"Ramaswamy","year":"2022","journal-title":"J Pers Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.5339\/gcsp.2014.54","article-title":"Arab gene geography: from population diversities to personalized medical genomics.","volume":"2014","author":"Tadmouri","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s13023-022-02545-w","article-title":"Expert Group Consensus on early diagnosis and management of infantile-onset pompe disease in the Gulf Region.","volume":"17","author":"Al-Hassnan","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jmd2.12062","article-title":"Extent, impact, and predictors of diagnostic delay in Pompe disease: a combined survey approach to unveil the diagnostic odyssey.","volume":"49","author":"Lagler","year":"2019","journal-title":"JIMD Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3889\/oamjms.2020.5167","article-title":"Management of mucopolysaccharidosis type i in Saudi Arabia: insights from Saudi Arabia.","volume":"8","author":"Al-Mayouf","year":"2020","journal-title":"Open Access Macedonian J Med Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses.","volume":"125","author":"Stapleton","year":"2018","journal-title":"Mol Genet Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/jimd.12099","article-title":"Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population.","volume":"42","author":"Al-Dewik","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12687-013-0153-1","article-title":"Genetic services and testing in the Sultanate of Oman. Sultanate of Oman steps into modern genetics.","volume":"4","author":"Rajab","year":"2013","journal-title":"J Community Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/s0022-3468(97)90015-4","article-title":"Hirschsprung\u2019s disease in Oman.","volume":"32","author":"Rajab","year":"1997","journal-title":"J Pediatr Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12887-025-05898-w","article-title":"The burden of delayed diagnosis in Hirschsprung disease: insights from a Paediatric Colorectal Centre in South Africa.","volume":"25","author":"Trovalusci","year":"2025","journal-title":"BMC Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3389\/fimmu.2018.03146","article-title":"Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population.","volume":"9","author":"Al-Herz","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.aller.2020.03.005","article-title":"Evaluation of the frequency and diagnostic delay of primary immunodeficiency disorders among suspected patients based on the 10 warning sign criteria: a cross-sectional study in Iran.","volume":"48","author":"Bahrami","year":"2020","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","article-title":"A guide for the diagnosis of rare and undiagnosed disease: beyond the exome.","volume":"14","author":"Marwaha","year":"2022","journal-title":"Genome Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.fmre.2022.09.002","article-title":"Rare and undiagnosed diseases: from disease-causing gene identification to mechanism elucidation.","volume":"2","author":"Wang","year":"2022","journal-title":"Fundam Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ajhg.2021.06.006","article-title":"Targeted long-read sequencing identifies missing disease-causing variation.","volume":"108","author":"Miller","year":"2021","journal-title":"Am J Hum Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s10038-019-0671-8","article-title":"Long-read sequencing for rare human genetic diseases.","volume":"65","author":"Mitsuhashi","year":"2020","journal-title":"J Hum Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1177204","DOI":"10.3389\/fgene.2023.1177204","article-title":"Spectrum of genetic disorders and gene variants in the United Arab Emirates national population: insights from the CTGA database.","volume":"14","author":"Bizzari","year":"2023","journal-title":"Front Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"16945","DOI":"10.1038\/s41598-022-20113-x","article-title":"Approaches to long-read sequencing in a clinical setting to improve diagnostic rate.","volume":"12","author":"Sanford Kobayashi","year":"2022","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1531583","DOI":"10.3389\/fpubh.2025.1531583","article-title":"The impact of rare diseases on the quality of life in paediatric patients: current status.","volume":"13","author":"Dumbuya","year":"2025","journal-title":"Front Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/humu.21293","article-title":"Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next-generation exome sequencing.","volume":"31","author":"Lalonde","year":"2010","journal-title":"Hum Mutat"},{"key":"B25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41576-020-0236-x","article-title":"Long-read human genome sequencing and its applications.","volume":"21","author":"Logsdon","year":"2020","journal-title":"Nat Rev Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexcr.2014.01.008","article-title":"Library preparation methods for next-generation sequencing: tone down the bias.","volume":"322","author":"van Dijk","year":"2014","journal-title":"Exp Cell Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41525-024-00454-4","article-title":"Long-read genome sequencing resolves complex genomic rearrangements in rare genetic syndromes.","volume":"9","author":"Showpnil","year":"2024","journal-title":"NPJ Genom Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/gim.2017.86","article-title":"Long-read genome sequencing identifies causal structural variation in a Mendelian disease.","volume":"20","author":"Merker","year":"2018","journal-title":"Genet Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.12688\/f1000research.7201.1","article-title":"MinION analysis and reference consortium: phase 1 data release and analysis.","volume":"4","author":"Ip","year":"2015","journal-title":"F1000Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1126\/science.1162986","article-title":"Real-time DNA sequencing from single polymerase molecules.","volume":"323","author":"Eid","year":"2009","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1139\/cjm-2023-0175","article-title":"Do we still need Illumina sequencing data? Evaluating Oxford Nanopore Technologies R10.4.1 flow cells and the Rapid v14 library prep kit for Gram negative bacteria whole genome assemblies.","volume":"70","author":"Lerminiaux","year":"2024","journal-title":"Can J Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"qzaf003","DOI":"10.1093\/gpbjnl\/qzaf003","article-title":"Long and accurate: how HiFi sequencing is transforming genomics.","volume":"23","author":"Wang","year":"2025","journal-title":"Genomics Proteomics Bioinformat"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/biom14111346","article-title":"Methods for detection and mapping of methylated and hydroxymethylated cytosine in DNA.","volume":"14","author":"Kisil","year":"2024","journal-title":"Biomolecules"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.354.6317.1220","article-title":"Qatar\u2019s genome effort slowly gears up.","volume":"354","author":"Kaiser","year":"2016","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/S00439-017-1821-8","article-title":"The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes.","volume":"136","author":"Monies","year":"2017","journal-title":"Hum Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/humu.24278","article-title":"Actionable genomic variants in 6045 participants from the Qatar Genome Program.","volume":"42","author":"Elfatih","year":"2021","journal-title":"Hum Mutat."},{"key":"B37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2741\/4757","article-title":"Precision medicine of monogenic disorders: lessons learned from the Saudi human genome.","volume":"24","author":"Abedalthagafi","year":"2019","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/ijms22042060","article-title":"Long-read sequencing improves the detection of structural variations impacting complex non-coding elements of the genome.","volume":"22","author":"Begum","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s41065-018-0069-1","article-title":"Long-read sequencing identified a causal structural variant in an exome-negative case and enabled preimplantation genetic diagnosis.","volume":"155","author":"Miao","year":"2018","journal-title":"Hereditas"},{"key":"B40","doi-asserted-by":"publisher","first-page":"100023","DOI":"10.1016\/j.xhgg.2021.100023","article-title":"Long-read genome sequencing for the molecular diagnosis of neurodevelopmental disorders.","volume":"2","author":"Hiatt","year":"2021","journal-title":"HGG Adv"},{"key":"B41","doi-asserted-by":"publisher","first-page":"117624","DOI":"10.1016\/j.cca.2023.117624","article-title":"Third-generation sequencing for genetic disease.","volume":"551","author":"Ling","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B42","doi-asserted-by":"publisher","first-page":"9907","DOI":"10.1038\/s41598-022-14038-8","article-title":"Analysis of rare thalassemia genetic variants based on third-generation sequencing.","volume":"12","author":"Peng","year":"2022","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jmedgenet-2018-105484","article-title":"Long-read sequencing identified intronic repeat expansions in SAMD12 from Chinese pedigrees affected with familial cortical myoclonic tremor with epilepsy.","volume":"56","author":"Zeng","year":"2019","journal-title":"J Med Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e64139","DOI":"10.1002\/ajmg.a.64139","article-title":"Resolving the diagnostic odyssey in inherited retinal dystrophies through long-read genome sequencing.","volume":"197","author":"Fabian-Morales","year":"2025","journal-title":"Am J Med Genet A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-025-02160-y","article-title":"Toward clinical long-read genome sequencing for rare diseases.","volume":"57","author":"Eisfeldt","year":"2025","journal-title":"Nat Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.36079\/lamintang.jamaps-0302.774","article-title":"Assessing the feasibility and challenges of CRISPR-Cas9 for treating genetic disorders in Colombia.","volume":"3","author":"Fern\u00e1ndez","year":"2024","journal-title":"J Adv Med Pharm Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biotech10030014","article-title":"Applications of CRISPR-Cas9 as an advanced genome editing system in life sciences.","volume":"10","author":"Tavakoli","year":"2021","journal-title":"BioTech (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering.","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9.","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering.","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"eadz1884","DOI":"10.1126\/science.adz1884","article-title":"Programmable genome editing in human cells using RNA-guided bridge recombinases.","volume":"391","author":"Pelea","year":"2026","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.engmic.2023.100123","article-title":"Advances and applications of CRISPR\/Cas-mediated interference in Escherichia coli.","volume":"4","author":"Lim","year":"2023","journal-title":"Eng Microbiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia.","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In vivo gene editing for transthyretin amyloidosis.","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene editing for CEP290-associated retinal degeneration.","volume":"390","author":"Pierce","year":"2024","journal-title":"N Engl J Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41586-026-10393-y","article-title":"Multicentre gene therapy for OTOF-related deafness followed up to 2.5 years.","volume":"653","author":"Jiang","year":"2026","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13073-020-00821-7","article-title":"Genetic variation in the Middle East-an opportunity to advance the human genetics field.","volume":"12","author":"Abou Tayoun","year":"2020","journal-title":"Genome Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing.","volume":"21","author":"Kantor","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e70040","DOI":"10.1002\/jgm.70040","article-title":"Prime editing: the next frontier in precision gene therapy.","volume":"27","author":"Aliciaslan","year":"2025","journal-title":"J Gene Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.1038\/s41467-025-63609-6","article-title":"A streamlined base editor engineering strategy to reduce bystander editing.","volume":"16","author":"Valdez","year":"2025","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.ymthe.2024.03.009","article-title":"In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice.","volume":"32","author":"B\u00f6ck","year":"2024","journal-title":"Mol Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"102185","DOI":"10.1016\/j.omtn.2024.102185","article-title":"Base editing in humanized dystrophic mice.","volume":"35","author":"Zhang","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41588-025-02172-8","article-title":"Base editing of trinucleotide repeats that cause Huntington\u2019s disease and Friedreich\u2019s ataxia reduces somatic repeat expansions in patient cells and in mice.","volume":"57","author":"Matuszek","year":"2025","journal-title":"Nat Genet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa2504835","article-title":"Base editing of HBG1 and HBG2 promoters for sickle cell disease.","volume":"394","author":"Gupta","year":"2026","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease.","volume":"392","author":"Musunuru","year":"2025","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.ymthe.2021.09.002","article-title":"In vivo somatic cell base editing and prime editing.","volume":"29","author":"Newby","year":"2021","journal-title":"Mol Ther"},{"key":"B68","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s44222-025-00360-z","article-title":"A clinical roadmap for base and prime editing.","volume":"3","author":"Flugel","year":"2025","journal-title":"Nat Rev Bioeng"},{"key":"B69","volume-title":"Long Term Follow-Up After Administration of Human Gene Therapy Products: Guidance for Industry.","year":"2020"},{"key":"B70","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA.","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41586-026-10395-w","article-title":"Quadruple pegRNA enables programmable and efficient large genomic insertion.","volume":"654","author":"Shi","year":"2026","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41587-023-01758-z","article-title":"Efficient prime editing in mouse brain, liver and heart with dual AAVs.","volume":"42","author":"Davis","year":"2024","journal-title":"Nat Biotechnol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1016\/j.cell.2025.06.038","article-title":"In vivo prime editing rescues alternating hemiplegia of childhood in mice.","volume":"188","author":"Sousa","year":"2025","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa2509807","article-title":"Prime editing for p47phox-deficient chronic granulomatous disease.","volume":"394","author":"Gori","year":"2026","journal-title":"N Engl J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e13808","DOI":"10.1111\/cpr.13808","article-title":"Prime editing: a revolutionary technology for precise treatment of genetic disorders.","volume":"58","author":"Li","year":"2025","journal-title":"Cell Prolif"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41591-026-04254-4","article-title":"In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial.","volume":"32","author":"Wan","year":"2026","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"eabq3202","DOI":"10.1126\/scitranslmed.abq3202","article-title":"Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice.","volume":"14","author":"Tang","year":"2022","journal-title":"Sci Transl Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"100890","DOI":"10.1016\/j.xinn.2025.100890","article-title":"Practical guideline for major hereditary thrombophilia.","volume":"6","author":"Tang","year":"2025","journal-title":"Innovation (Camb)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2016.10.044","article-title":"CRISPR-based technologies for the manipulation of eukaryotic genomes.","volume":"168","author":"Komor","year":"2017","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1126\/science.aab1028","article-title":"Biotechnology. A prudent path forward for genomic engineering and germline gene modification.","volume":"348","author":"Baltimore","year":"2015","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41586-025-09720-6","article-title":"Estimation and mapping of the missing heritability of human phenotypes.","volume":"649","author":"Wainschtein","year":"2026","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1038\/s41467-019-11955-7","article-title":"Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements.","volume":"10","author":"Tycko","year":"2019","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12967-023-04243-y","article-title":"Implementation of Nanopore sequencing as a pragmatic workflow for copy number variant confirmation in the clinic.","volume":"21","author":"Greer","year":"2023","journal-title":"J Transl Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"801819","DOI":"10.3389\/fcell.2021.801819","article-title":"An integrated approach to studying rare neuromuscular diseases using animal and human cell-based models.","volume":"9","author":"Hines","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17460751.2025.2480003","article-title":"The future of ex vivo hematopoietic stem cell gene editing: what\u2019s next.","volume":"20","author":"Cavazza","year":"2025","journal-title":"Regen Med"},{"key":"B86","volume-title":"Human Genome Editing: Recommendations.","year":"2021"},{"key":"B87","first-page":"3","article-title":"Introduction.","volume-title":"Islamic Ethics and the Genome Question.","author":"Ghaly","year":"2018"},{"key":"B88","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195378504.001.0001","volume-title":"Islamic Biomedical Ethics: Principles and Application.","author":"Sachedina","year":"2009"},{"key":"B89","volume-title":"Federal Decree-Law No. 49 of 2023 on the Regulation of the Use of the Human Genome.","year":"2023"},{"key":"B90","first-page":"12","article-title":"Sharia scholars and modern biomedical advancements.","volume-title":"Islamic Ethics and the Genome Question.","author":"Ghaly","year":"2018"},{"key":"B91","volume-title":"Proceedings of the Sixteenth Session of the Islamic Fiqh Academy in Makkah.","year":"2002"},{"key":"B92","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1467-8519.2009.01712.x","article-title":"Islamic medical ethics: A primer.","volume":"24","author":"Padela","year":"2010","journal-title":"Bioethics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrg1505","article-title":"Human genetic research: emerging trends in ethics.","volume":"6","author":"Knoppers","year":"2005","journal-title":"Nat Rev Genet"},{"key":"B94","volume-title":"Implementing Regulations of the Law of Ethics of Research on Living Creatures.","year":"2010"},{"key":"B95","volume-title":"Law No. 13 of 2016 Concerning Personal Data Protection.","year":"2016"},{"key":"B96","doi-asserted-by":"publisher","first-page":"eabq3010","DOI":"10.1126\/scitranslmed.abq3010","article-title":"Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia.","volume":"14","author":"Ottaviano","year":"2022","journal-title":"Sci Transl Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1859881\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:10:23Z","timestamp":1783336223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1859881\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":96,"alternative-id":["10.3389\/fmed.2026.1859881"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1859881","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1859881"}}